Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marianne Andersen

Showing results (21-30 of 127) with videos related to

Pageof 13
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 7, 2015
Fracture Risk Is Decreased in Women With Polycystic Ovary Syndrome: A Register-Based and Population-Based Cohort StudyKatrine Hass Rubin, Dorte Glintborg, Mads Nybo, et al.
The Journal of Clinical Endocrinology and Metabolism|September 23, 2017
Development and Risk Factors of Type 2 Diabetes in a Nationwide Population of Women With Polycystic Ovary SyndromeKatrine Hass Rubin, Dorte Glintborg, Mads Nybo, et al.
Endocrine Connections|September 14, 2019
Increased risk of thyroid disease in Danish women with polycystic ovary syndrome: a cohort studyDorte Glintborg, Katrine Hass Rubin, Mads Nybo, et al.
Cardiovascular Diabetology|March 10, 2018
Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndromeDorte Glintborg, Katrine Hass Rubin, Mads Nybo, et al.
Communication & Medicine|February 7, 2014
Supportive relationships--psychological effects of group counselling in women with polycystic ovary syndrome (PCOS)Kirsten K Roessler, Dorte Glintborg, Pernille Ravn, et al.
The Journal of Clinical Endocrinology and Metabolism|February 21, 2008
Association of pioglitazone treatment with decreased bone mineral density in obese premenopausal patients with polycystic ovary syndrome: a randomized, placebo-controlled trialDorte Glintborg, Marianne Andersen, Claus Hagen, et al.
European Journal of Endocrinology|February 7, 2015
Morbidity and medicine prescriptions in a nationwide Danish population of patients diagnosed with polycystic ovary syndromeDorte Glintborg, Katrine Hass Rubin, Mads Nybo, et al.
Age (Dordrecht, Netherlands)|February 25, 2011
Testosterone therapy increased muscle mass and lipid oxidation in aging menLouise Frederiksen, Kurt Højlund, David M Hougaard, et al.
European Journal of Endocrinology|June 26, 2003
Development of acromegaly in patients with prolactinomasMarianne Andersen, Casper Hagen, Jan Frystyk, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|July 21, 2011
Smoking is associated with increased adrenal responsiveness, decreased prolactin levels and a more adverse lipid profile in 650 white patients with polycystic ovary syndromeDorte Glintborg, Hanne Mumm, David M Hougaard, et al.
Pageof 13

Showing results (21-30 of 127) with videos related to

Sort By:
Pageof 13
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 7, 2015
Fracture Risk Is Decreased in Women With Polycystic Ovary Syndrome: A Register-Based and Population-Based Cohort StudyKatrine Hass Rubin, Dorte Glintborg, Mads Nybo, et al.
The Journal of Clinical Endocrinology and Metabolism|September 23, 2017
Development and Risk Factors of Type 2 Diabetes in a Nationwide Population of Women With Polycystic Ovary SyndromeKatrine Hass Rubin, Dorte Glintborg, Mads Nybo, et al.
Endocrine Connections|September 14, 2019
Increased risk of thyroid disease in Danish women with polycystic ovary syndrome: a cohort studyDorte Glintborg, Katrine Hass Rubin, Mads Nybo, et al.
Cardiovascular Diabetology|March 10, 2018
Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndromeDorte Glintborg, Katrine Hass Rubin, Mads Nybo, et al.
Communication & Medicine|February 7, 2014
Supportive relationships--psychological effects of group counselling in women with polycystic ovary syndrome (PCOS)Kirsten K Roessler, Dorte Glintborg, Pernille Ravn, et al.
The Journal of Clinical Endocrinology and Metabolism|February 21, 2008
Association of pioglitazone treatment with decreased bone mineral density in obese premenopausal patients with polycystic ovary syndrome: a randomized, placebo-controlled trialDorte Glintborg, Marianne Andersen, Claus Hagen, et al.
European Journal of Endocrinology|February 7, 2015
Morbidity and medicine prescriptions in a nationwide Danish population of patients diagnosed with polycystic ovary syndromeDorte Glintborg, Katrine Hass Rubin, Mads Nybo, et al.
Age (Dordrecht, Netherlands)|February 25, 2011
Testosterone therapy increased muscle mass and lipid oxidation in aging menLouise Frederiksen, Kurt Højlund, David M Hougaard, et al.
European Journal of Endocrinology|June 26, 2003
Development of acromegaly in patients with prolactinomasMarianne Andersen, Casper Hagen, Jan Frystyk, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|July 21, 2011
Smoking is associated with increased adrenal responsiveness, decreased prolactin levels and a more adverse lipid profile in 650 white patients with polycystic ovary syndromeDorte Glintborg, Hanne Mumm, David M Hougaard, et al.
Pageof 13